Bristol Myers Squibb is a global biopharma leader in immuno-oncology, hematology, and cardiovascular disease. Its checkpoint inhibitor and CAR-T cell therapy programs grew from extensive academic partnerships and translational research.
R&D SPEND
$9.3B
INDUSTRY
Biopharma
480
ACADEMIC COLLABORATIONS
7200
PATENTS
TRY IT
Install the CLI and run your first search in under a minute. No account required to explore.
npx sci-buy@latest COPIED